Glenmark Pharma arm launches generic Methylene Blue Injection in US market
2026-06-17 15:05:18Glenmark Pharma arm launches generic Methylene Blue Injection in US market Business Standard...
Read MoreGlenmark Pharma arm launches generic Methylene Blue Injection in US market
2026-06-17 15:05:18Glenmark Pharma arm launches generic Methylene Blue Injection in US market Business Standard...
Read MoreStock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom
2026-06-10 09:05:04Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom Business Standard...
Read MoreGlenmark Pharma launches generic Lacosamide injection in US
2026-06-05 10:31:02Glenmark Pharma launches generic Lacosamide injection in US Business Standard...
Read MoreAfter a dull Q4, Glenmark Pharma needs a booster shot to grow
2026-06-02 16:24:36After a dull Q4, Glenmark Pharma needs a booster shot to grow Mint...
Read MoreGlenmark, Auro Pharma, Wockhardt: Top pharma stocks to trade Key levels, targets & more
2026-06-02 08:36:12Glenmark, Auro Pharma, Wockhardt: Top pharma stocks to trade Key levels, targets & more Business Today...
Read MoreStock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL
2026-06-01 09:04:12Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL Business Standard...
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
11-Jun-2026 | Source : BSEGlenmark launches Winlevi (clascoterone) 10 mg/g cream in Key European Markets for the Treatment of Acne Vulgaris
Announcement under Regulation 30 (LODR)-Investor Presentation
09-Jun-2026 | Source : BSEPlease find attached Investor Presentation to be made at Glenmark Pharmaceuticals Limited Investor Day 2026 today.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
05-Jun-2026 | Source : BSEGlenmark Pharmaceuticals Inc. USA launches Lacosamide Injection USP 200 mg/ 20mL (10 mg/mL) Single-Dose Vials
Corporate Actions
No Upcoming Board Meetings
Glenmark Pharmaceuticals Ltd. has declared 250% dividend, ex-date: 03 Oct 25
Glenmark Pharmaceuticals Ltd. has announced 1:2 stock split, ex-date: 10 Sep 07
No Bonus history available
No Rights history available